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International Symposium in Nuclear
Oncology, Porto Allegre, Brazil,
January 19th–24th, 2004
In the period 19/24 January 2004 in Porto Allegre, Brazil,
the International Symposium in Nuclear Oncology was held, orga-
nized by the IAEA and Association of Nuclear Medicine of Brazil.
The symposium structure, selection of lecturers, thematic con-
cept enabled an original cosmopolitan combination of experts
and specialists in nuclear medicine of various ages and practi-
cal experience, who shed light on nuclear oncology from differ-
ent aspects. In 16 oral and 2 poster sessions within the invited
and working lectures, the participants from 57 countries present-
ed in an interesting and educative way the most up-to-date
achievements in diagnostic and therapeutic application of radio-
nuclide in oncology. It was also a unique chance for the coun-
tries from our (Balkan) region to demonstrate its results and de-
termine the actual nuclear-oncologic position related to other
countries worldwide.
Many of the most eminent experts in nuclear medicine
(M-C. Lee, A. Alavi, H.M. Abdel-Dayem, K. Britton, J. Buscombe,
A. Al-Nahhas, I. Srivastava, I. Amaral, F. Corstens, S. Goldsmith)
contributed to the various symposium contents and to its suc-
cessful work. However, the central symposium individuals were
Prof. Ajit Padhy as the official IAEA representative and the in-
genious symposium creator and Dr Anselmo Osvaldo, as the
symposium host on behalf of the host-country, in charge of the
organizational-technical issues. Each one of them greatly con-
tributed to their own activity domain and did their best so that
the symposium could be held in a warm and friendly atmo-
sphere.
Social life was very diverse and skillfully incorporated into the
exotic environment of Brazil. The evening of national dances and
tasting wine from the participating countries will be remembered
also by its message that regardless of the cultural differences we
belong to the same human family.
The symposium in Porto Allegre will remain a pleasant mem-
ory for all the participants. It was a good and original idea of
the IAEA to try to bring different people together working on the
problem common to all. “The Wonderful World of Nuclear Med-
icine”, the term used by Prof. Padhy in his emotional Final High-
lights, tried to formulate the road of its own development in the
future.
Prof. Slobodan Illić
Department of Nuclear Medicine
18000, Niš, Serbia
Tel: (+381) 18 324 364, fax: (+ 381) 18 336 338
e-mail: lorens@bankerinter.net
Nuclear medicine in South-Eastern Europe,
Second Workshop of South-Eastern European
Countries, Stubicke Toplice, March 27th, 2004
Organized by the Associations of Nuclear Medicine from Croatia
and Slovenia, the Second Workshop of South-Eastern European
Countries (Balkan countries would perhaps be more precise geo-
graphic determinant), was held on March 27 in Stubicke Toplice,
Croatia. In addition to the former Yugoslav republics, now indepen-
dent countries: Slovenia, Croatia, Bosnia and Herzegovina, Mace-
donia, Serbia and Montenegro, participants of the workshop were
also represented by Albania (for the first time) and Romania, while
Bulgaria cancelled its participation at the last moment.
The workshop had a dynamic and interactive concept which was
disseminated through introductory lectures, presentations of the
participating countries, round table discussions and closure com-
ments (summary and standardization of the workshop contents).
The themes of the workshop were the diagnosis and therapy of thy-
roid carcinoma and lung scintigraphy. The introductory lectures were
given by eminent experts from the respective fields: Prof. P. Lind
(Austria), Prof. W. Knapp (Germany), Dr Adil Al-Nahhas (United King-
dom) and Dr. Marika Bajc (Sweden). In addition to the official nation-
al delegates, a large number of nuclear medicine specialists, endo-
crinologists, physicists and radiopharmacologists also took part.
Representatives from various countries presented the present
position of nuclear medicine in their respective countries, through
information on the number and localization of centers, equipment,
staff situation, and yearly frequency of analyses performed. The
thematic part, followed by a round table discussion, aimed to stan-
dardize the general diagnostic and therapeutic guidelines for thy-
roid carcinoma and lung scintigraphy based on the obtained data,
present situation and present achievements in those fields.
It was the general impression of all workshop participants, that
this type of meeting is extremely useful since it enables participants
to acquire new knowledge and exchange information with co-
lleagues in a relatively short period of time via an intense thematic
programme. As regards the professional aspects, the most useful
one is perhaps making new contacts and friendships which should
contribute to the development of nuclear medicine in the region.
The third, it may well be already said, traditional nuclear med-
icine workshop of the south-eastern European countries will be
held in Opatija, 15/18 May 2005, during the V International Con-
gress of the Croatian Association of Nuclear Medicine.
Prof. Slobodan Illić
Department of Nuclear Medicine
18000, Niš, Serbia
Tel: (+381) 18 324 364, fax: (+ 381) 18 336 338
e-mail: lorens@bankerinter.net
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Seminar — Functional Radioiodtherapy,
Greifswald, Land Pomerania, Germany,
April, 21st, 2004
Seminar on functional radioiodine therapy (RIT), organized by
Prof. Gerhard Kirsch from Greifswald was the pre-congress meet-
ing of German SNM Congress in Rostock. It was a small meeting;
with mostly local participants but its contents was very interesting
and worth to be discussed.
Radioidine therapy is very well developed in Germany and the
contents of the meeting were focused mostly on technical devel-
opments around the treatment of benign thyroid disorders.
Prof. Kirsch in his introduction characterized the basic con-
cepts of planning, conducting and measurements in this treat-
ment. M. Luhn characterized the dosimetry models of RIT, Marinelli
formula, MIRD concepts. S. Ertl from Berlin discussed the role of
probe vs. gammacamera measurement in thyroid uptake deter-
mination and showed his concepts of specially designed 16 cm
long (!) collimator for uptake measurement. A. Zinke showed the
special patient self-measured chip-card device, which patient uses
during his hospitalization (in Germany patients following RIT ther-
apy are hospitalized). Data are automatically sent to the clinic RIT
data-base, very cleverly designed by G. Scheller from the same
centre.
Second part of the meeting was focused on the philosophy of
RIT and hear was the heart of the matter. German legislation is
probably one of the most complex in Europe. It assumes of pa-
tient’s hospital stay of at least 5 days. Patient has a radioiodine
uptake measured at least 2–3 times, at least at 6, 24, 48 hours
post RI administration and careful dosimetric assessment of thy-
roid. Patient has thyroid scintigraphy done at least two times dur-
ing his hospital stay, numerous thyroid hormones serum levels
assessments, bone densitometry, photography of eyes and neck
before and after RIT an what else not…
Radioiodine is administered intravenously and if dosimetric
studies reveal that an absorbed dosis is too low, a re-injection
of radioiodine is performed to achieve an optimal absorbed dosis.
As told, this is performed in-patient, hospital stay lasts at least
5 day, but — with some bad luck — may last a couple of days.
This costs about 2.800 euro.
Prof. Piotr Lass from Gdańsk, Poland presented a model ap-
plied in Poland. Patients are treated out-patient manner; they under-
go a single RI uptake measurement before RIT, with a single 24 hours
— measurement. Diagnostic tests include one scintigraphy and USG,
first post-RIT hormone assay done at earliest 2–3 weeks post-thera-
py. Additional diagnostic tests — FNB, thyroid antibodies assay are
performed optionally. The cost of RIT in Poland is between 100–
–200 euro, depending on the number of diagnostic tests performed.
This comparison exerted a lively dispute, on which model is
better. Is Polish model under regulated, German overregulated or
the truth lies somewhere in between? How much German model
really serves the patient and how much it is a by-product of gov-
ernmental bureaucracy? How long the health insurance will by
able to pay such a costs?
This is a very important issue in the eve of entering the new
members into the European Union. How much common health
— incl. RIT — legislation will be necessary for the benefit of pa-
tients, how much will be the producing Brussels bureaucrats? This
meeting was for me a nice occasion to over-think such issues on
example of RIT.
A few words about Greifswald, a small charming city in the
North-Eastern edge of Germany. Greifswald is deeply in my heart,
as a long time ago I was a frequent guest there as the young
doctor. Greifswald is small but important university city. Ernst-
Moritz-Arndt University has been established in year 1456 by Po-
meranian prince Wartislav IXth and Greifswald Mayor Rubenow
— as the first or second university at Baltic Sea. It survived su-
ccessfully the World War II — a rare example in eastern part
of Germany — and today is a peaceful city with crowd of students
cycling everywhere and giving the city a youthful look. A very nice
place for such a meeting.
Prof. Piotr Lass
Department of Nuclear Medicine
Medical University
80–211 Gdańsk, Poland
tel/fax: (+48 58) 349 22 04, e-mail: plass@amg.gda.pl
